Login / Signup

Peptide Dendrimer-Based Antibacterial Agents: Synthesis and Applications.

Suchita PaulSandeep VermaYu-Chie Chen
Published in: ACS infectious diseases (2024)
Pathogenic bacteria cause the deaths of millions of people every year. With the development of antibiotics, hundreds and thousands of people's lives have been saved. Nevertheless, bacteria can develop resistance to antibiotics, rendering them insensitive to antibiotics over time. Peptides containing specific amino acids can be used as antibacterial agents; however, they can be easily degraded by proteases in vivo . To address these issues, branched peptide dendrimers are now being considered as good antibacterial agents due to their high efficacy, resistance to protease degradation, and low cytotoxicity. The ease with which peptide dendrimers can be synthesized and modified makes them accessible for use in various biological and nonbiological fields. That is, peptide dendrimers hold a promising future as antibacterial agents with prolonged efficacy without bacterial resistance development. Their in vivo stability and multivalence allow them to effectively target multi-drug-resistant strains and prevent biofilm formation. Thus, it is interesting to have an overview of the development and applications of peptide dendrimers in antibacterial research, including the possibility of employing machine learning approaches for the design of AMPs and dendrimers. This review summarizes the synthesis and applications of peptide dendrimers as antibacterial agents. The challenges and perspectives of using peptide dendrimers as the antibacterial agents are also discussed.
Keyphrases
  • drug resistant
  • silver nanoparticles
  • machine learning
  • biofilm formation
  • essential oil
  • escherichia coli
  • multidrug resistant
  • staphylococcus aureus
  • pseudomonas aeruginosa
  • amino acid
  • wound healing
  • cystic fibrosis